Atypical chronic myelogenous leukemia following immunosuppressive therapy for severe aplastic anemia

Leuk Lymphoma. 1999 Sep;35(1-2):193-9. doi: 10.3109/10428199909145719.

Abstract

Late clonal complications of aplastic anemia (AA) such as acute leukemia, myelodysplastic syndromes or paroxysmal nocturnal hemoglobinuria have been recognized for a long time. To our knowledge, chronic myelogenous leukemia (CML) as a late complication of severe aplastic anemia has as yet not been reported. We report here a case of AA treated successfully with antilymphocytic globulin and cyclosporin in whom Ph1 negative, BCR/ABL negative CML developed 8 years after diagnosis of AA. This case of atypical, secondary CML was refractory to treatment with interferon alpha and hydroxyurea.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anemia, Aplastic / drug therapy*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Karyotyping
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / etiology*
  • Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / etiology*
  • Male
  • Treatment Outcome

Substances

  • Immunosuppressive Agents